Jarecki Jaromir, Tomczyk-Warunek Agnieszka, Wicha Mateusz, Horecka Anna, Blicharski Rudolf, Dobrzyński Maciej
CHAIR AND DEPARTMENT OF REHABILITATION AND ORTHOPAEDICS, MEDICAL UNIVERSITY OF LUBLIN, LUBLIN, POLAND.
CHAIR AND DEPARTMENT OF MEDICAL CHEMISTRY, MEDICAL UNIVERSITY OF LUBLIN, LUBLIN, POLAND.
Wiad Lek. 2020;73(9 cz. 1):1818-1823.
Arthrosis as osteoarthritis is a global problem that affects more and more people and is associated with severe chronic pain, reduced mobility and, consequently, disability. The etiology of degenerative disease is complex and depends on many factors. However, its course was not fully understood. One of the factors affecting the development of arthrosis is obesity. Obesity is a growing problem. Over the past 30 years, the number of overweight people has almost doubled. In people suffering from obesity, whose body mass index is above 30kg/m2, the risk of developing degenerative changes in articular cartilage is six times higher than the risk of developing this disease in people with normal body weight. Osteoarthritis is detected when the symptoms get worse where the changes are already at some stage. Therefore, a lot of research is currently underway to find suitable biomarkers, which would indicate the potential development of degenerative changes in the future and at the same time the possibility of inhibiting their activity. One of them may be adipokines, which are synthesized by adipose tissue and affect cartilage. In obese people, adipokines may contribute to the inflammation of the low charterer, whichaccompanies both obesity and arthrosis. These compounds can be specific biomarkers to assess the degree of progression and severity of osteoarthritis. The aim: To assess the importance of obesity and adipokines produced by adipose tissue as specific markers of arthrosis.
作为骨关节炎的关节病是一个全球性问题,影响着越来越多的人,并且与严重的慢性疼痛、活动能力下降以及随之而来的残疾相关。退行性疾病的病因复杂,取决于多种因素。然而,其病程尚未完全明了。影响关节病发展的因素之一是肥胖。肥胖是一个日益严重的问题。在过去30年里,超重人群数量几乎翻了一番。在体重指数高于30kg/m²的肥胖人群中,关节软骨发生退行性改变的风险比正常体重人群患此病的风险高六倍。当症状加重且变化已处于某个阶段时,骨关节炎才被检测出来。因此,目前正在进行大量研究以寻找合适的生物标志物,这些生物标志物既能表明未来退行性改变的潜在发展,又能同时表明抑制其活动的可能性。其中之一可能是脂肪因子,它由脂肪组织合成并影响软骨。在肥胖人群中,脂肪因子可能导致低级别炎症,这种炎症在肥胖和关节病中都存在。这些化合物可以作为评估骨关节炎进展程度和严重程度的特异性生物标志物。目的:评估肥胖以及脂肪组织产生的脂肪因子作为关节病特异性标志物的重要性。